Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.

Chiara Bottelli, Alessandra Tucci, Stefano Luminari, Luca Arcaini, Michele Merli, Alessandro Pulsoni, Carola Boccomini, Benedetta Puccini, Moira Micheletti, Giovanni Martinelli, Andrea Rossi, Vittorio Ruggero Zilioli, Valentina Bozzoli, Monica Balzarotti, Silvia Bolis, Maria Giuseppina Cabras, Massimo Federico, Giuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi. American Journal of Hematology. ,vol. 90, pp. 56- 61 ,(2015) , 10.1002/AJH.23872

Paul V. Beum, Margaret A. Lindorfer, Ronald P. Taylor, Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving. Journal of Immunology. ,vol. 181, pp. 2916- 2924 ,(2008) , 10.4049/JIMMUNOL.181.4.2916

J S Weber, J C Yang, S L Topalian, D J Schwartzentruber, D E White, S A Rosenberg, The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma. Journal of Clinical Oncology. ,vol. 10, pp. 33- 40 ,(1992) , 10.1200/JCO.1992.10.1.33

Santiago Coca, Javier Perez-Piqueras, David Martinez, Antonio Colmenarejo, Miguel A. Saez, Carmen Vallejo, Jose A. Martos, Manuel Moreno, The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma Cancer. ,vol. 79, pp. 2320- 2328 ,(1997) , 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P

Mustaqeem Siddiqui, Kay Ristow, Svetomir N. Markovic, Thomas E. Witzig, Thomas M. Habermann, Joseph P. Colgan, David J. Inwards, William L. White, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Timothy G. Call, Luis F. Porrata, Absolute lymphocyte count predicts overall survival in follicular lymphomas British Journal of Haematology. ,vol. 134, pp. 596- 601 ,(2006) , 10.1111/J.1365-2141.2006.06232.X

E Decaup, C Jean, C Laurent, P Gravelle, S Fruchon, F Capilla, A Marrot, T Al Saati, F-X Frenois, G Laurent, C Klein, N Varoqueaux, A Savina, J-J Fournié, C Bezombes, Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model. Blood Cancer Journal. ,vol. 3, ,(2013) , 10.1038/BCJ.2013.32

Daphne de Jong, Thierry Fest, The microenvironment in follicular lymphoma Best Practice & Research Clinical Haematology. ,vol. 24, pp. 135- 146 ,(2011) , 10.1016/J.BEHA.2011.02.007

Vincent K. Nganga, Victoria L. Palmer, Hina Naushad, Michele D. Kassmeier, Dirk K. Anderson, Greg A. Perry, Nathan M. Schabla, Patrick C. Swanson, Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1. Blood. ,vol. 121, pp. 3855- 3866 ,(2013) , 10.1182/BLOOD-2012-08-446732

Ricardo García-Muñoz, Jesús Feliu, Luis Llorente, The top ten clues to understand the origin of chronic lymphocytic leukemia (CLL). Journal of Autoimmunity. ,vol. 56, pp. 81- 86 ,(2015) , 10.1016/J.JAUT.2014.10.005

Ricardo García-Muñoz, Luis Llorente, Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms? Immunology. ,vol. 142, pp. 536- 550 ,(2014) , 10.1111/IMM.12285